Opsonized zymosan
Proton secretion by the sodium/hydrogen ion antiporter in the human neutrophil
8
The Chemiluminescence Response and Bactericidal Activity of Polymorphonuclear Neutrophils From Newborns and Their Mothers
8
Regulation of human monocyte/macrophage function by extracellular matrix Adherence of monocytes to collagen matrices enhances phagocytosis of opsonized bacteria by activation of complement receptors and enhancement of Fc receptor function
13
The origin of the chemiluminescence of phagocytosing granulocytes
9
Enhancement of Neutrophil Function as a Result of Prior Exposure to Chemotactic Factor
10
Priming of polymorphonuclear neutrophils by atrial natriuretic peptide in vitro
8
Syk phosphorylation – a gravisensitive step in macrophage signalling
9
Deficiency of a surface membrane glycoprotein (Mo1) in man
8
Comparative study of neutrophil activation by chemiluminescence and flow cytometry.
9
Further characterization of NADPH oxidase activity of human polymorphonuclear leukocytes
8
Human monocyte derived mucus secretagogue
9
Inflammation and enhanced nociceptive responses to bladder distension produced by intravesical zymosan in the rat
7
LOX-1-deficient mice are resistant to zymosan-induced arthritis: A mini review
6
A living cell quartz crystal microbalance biosensor for continuous monitoring of cytotoxic responses of macrophages to single-walled carbon nanotubes
17
Termination of the Respiratory Burst in Human Neutrophils
11
Original Article Role of biphasic changes in splenic dendritic cell activity in a mouse model of multiple organ dysfunction syndrome
14
Impaired neonatal macrophage phagocytosis is not explained by overproduction of prostaglandin E2
9
In vitro suppression of serum elastase inhibitory capacity by reactive oxygen species generated by phagocytosing polymorphonuclear leukocytes
6
Delayed resolution of acute inflammation during zymosan induced arthritis in leptin deficient mice
8
Multifunctional serine protease inhibitor coated water soluble gold nanoparticles as a novel targeted approach for the treatment of inflammatory skin diseases
48